DI MICCO, PIERLUIGI
 Distribuzione geografica
Continente #
AS - Asia 1.532
NA - Nord America 876
EU - Europa 578
SA - Sud America 215
AF - Africa 58
OC - Oceania 1
Totale 3.260
Nazione #
US - Stati Uniti d'America 833
SG - Singapore 702
RU - Federazione Russa 349
VN - Vietnam 306
CN - Cina 296
BR - Brasile 172
HK - Hong Kong 78
DE - Germania 55
IT - Italia 43
GB - Regno Unito 33
FR - Francia 31
KR - Corea 31
CA - Canada 24
IN - India 23
CI - Costa d'Avorio 22
BD - Bangladesh 19
AR - Argentina 16
AT - Austria 16
JP - Giappone 15
ZA - Sudafrica 14
MX - Messico 12
TH - Thailandia 10
ID - Indonesia 8
NL - Olanda 8
EC - Ecuador 7
PH - Filippine 7
PL - Polonia 6
SE - Svezia 6
UA - Ucraina 6
ES - Italia 5
IL - Israele 5
IQ - Iraq 5
MA - Marocco 5
TW - Taiwan 5
VE - Venezuela 5
CL - Cile 4
CO - Colombia 4
JO - Giordania 4
KE - Kenya 4
FI - Finlandia 3
LT - Lituania 3
MD - Moldavia 3
PY - Paraguay 3
AZ - Azerbaigian 2
BE - Belgio 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
KG - Kirghizistan 2
MK - Macedonia 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
TN - Tunisia 2
TR - Turchia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BJ - Benin 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
NG - Nigeria 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
ZM - Zambia 1
Totale 3.260
Città #
Singapore 406
San Jose 195
Hefei 140
Moscow 88
Ashburn 85
Ho Chi Minh City 84
Santa Clara 80
Hong Kong 76
Hanoi 64
Beijing 61
Seoul 25
Los Angeles 24
Da Nang 21
Lauterbourg 20
New York 20
São Paulo 17
Haiphong 15
Redondo Beach 15
The Dalles 15
Frankfurt am Main 14
Buffalo 12
London 12
Nuremberg 11
Tokyo 11
Orem 10
Toronto 10
Denver 9
Düsseldorf 9
Chennai 8
Amsterdam 7
Atlanta 7
Campinas 7
Chandler 7
Johannesburg 7
Brooklyn 6
Mexico City 6
Rio de Janeiro 6
Seattle 6
Stockholm 6
Vienna 6
Bangkok 5
Belo Horizonte 5
Biên Hòa 5
Brasília 5
Chicago 5
Kronberg 5
Manchester 5
Naples 5
Ninh Bình 5
Ottawa 5
Phoenix 5
Warsaw 5
Boston 4
Council Bluffs 4
Dong Ket 4
Juiz de Fora 4
Montreal 4
Munich 4
Poplar 4
Rome 4
Sorocaba 4
Thái Bình 4
Amman 3
Bexley 3
Bắc Ninh 3
Charlotte 3
Dallas 3
Dhaka 3
Fairfield 3
Fortaleza 3
Houston 3
Itaquaquecetuba 3
Lawrence 3
Manaus 3
Marcon 3
Millbury 3
Nairobi 3
Phủ Lý 3
Quito 3
São José 3
Turku 3
Wilmington 3
Zhongli District 3
Agadir 2
Ahmedabad 2
Baghdad 2
Baku 2
Bethlehem 2
Blumenau 2
Brussels 2
Camden 2
Caraguatatuba 2
Chisinau 2
City of London 2
Ciudad del Este 2
Concepción 2
Concord 2
Durban 2
Falkenstein 2
Hangzhou 2
Totale 1.825
Nome #
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 193
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation 156
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism 142
Long-term anticoagulant therapy of patients with venous thromboembolism. What are the practices? 140
Fondaparinux in the initial and long-term treatment of venous thromboembolism 137
Predictors of active cancer thromboembolic outcomes: RIETE experience of the Khorana score in cancer-associated thrombosis 134
Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients 133
Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy 128
First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry 127
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry 121
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE 118
Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism 118
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity 117
Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project 113
Early use of echocardiography in patients with acute pulmonary embolism: Findings from the RIETE registry 109
Management of isolated distal deep–vein thrombosis with direct oral anticoagulants in the RIETE registry 105
Sex differences in patients receiving anticoagulant therapy for venous thromboembolism 105
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism 104
Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis 104
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism 99
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism 98
Venous thromboembolism in patients immobilised at home 97
Idiopathic hypereosinophilia and venous thromboembolism: Is there a pathophysiological or clinical link? description of an intriguing clinical case 96
DVT Management and Outcome Trends, 2001 to 2014 96
Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism 94
The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site 93
Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry 85
Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry. 52
ANALYSIS ON THE OUTCOME OF ITALIAN PATIENTS WITH DEEP VEIN THROMBOSIS TREATED WITH CLASSIC ANTICOAGULANTS: DATA FROM THE RIETE REGISTRY 50
Edoxaban for the Long-Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised? 19
Can LDL-C be too low? Time to rethink the "lower is better" paradigm 8
Totale 3.291
Categoria #
all - tutte 10.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.291


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/202217 0 3 0 0 1 0 0 1 5 0 3 4
2022/202375 3 0 0 3 2 2 0 49 5 5 5 1
2023/2024144 3 11 30 12 8 4 4 35 1 5 23 8
2024/2025877 41 49 3 1 65 49 79 54 62 79 310 85
2025/20262.165 208 203 246 278 368 93 221 114 288 99 47 0
Totale 3.291